Mercado de globos de angioplastia: mapeo competitivo y perspectivas estratégicas para 2030

  • Report Code : TIPHE100001278
  • Category : Medical Device
  • Status : Data Released
  • No. of Pages : 150
Buy Now

[Informe de investigación] Se proyecta que el mercado de balones de angioplastia crecerá de 2,71 mil millones de dólares en 2022 a 3,60 mil millones de dólares en 2030, registrando una tasa compuesta anual del 3,6% de 2022 a 2030.

Perspectivas del mercado y visión de analista:

El pronóstico del mercado de balones de angioplastia puede ayudar a las partes interesadas en este mercado a planificar sus estrategias de crecimiento. El informe incluye perspectivas de crecimiento, junto con las tendencias del mercado de globos de angioplastia y su impacto previsible durante el período de pronóstico.

Una angioplastia es una técnica utilizada para ensanchar o abrir arterias coronarias obstruidas y restaurar el flujo sanguíneo. La atención basada en el valor, que se centra en la rentabilidad y los resultados para los pacientes, está cambiando el sector sanitario. El mercado de los balones de angioplastia se verá influenciado por la capacidad de estos dispositivos para proporcionar mejores resultados para los pacientes, tasas reducidas de revascularización y costos más bajos en comparación con otros tratamientos disponibles. En comparación con los métodos quirúrgicos convencionales, los balones de angioplastia proporcionan un método menos invasivo para tratar las arterias obstruidas. La necesidad de balones de angioplastia está aumentando a medida que los pacientes y los profesionales médicos muestran una mayor preferencia por procedimientos menos invasivos. La creciente prevalencia de enfermedades cardiovasculares y la creciente preferencia por procedimientos mínimamente invasivos contribuyen al creciente tamaño del mercado de balones de angioplastia. Sin embargo, las complicaciones asociadas con la angioplastia impiden el crecimiento del mercado.

Impulsores de crecimiento:

El aumento de la prevalencia de enfermedades cardiovasculares impulsa el mercado de globos de angioplastia

Según la Organización Mundial de la Salud ( OMS), las enfermedades cardiovasculares son la causa más importante de morbilidad y mortalidad en todo el mundo. Las enfermedades cardiovasculares incluyen la enfermedad cerebrovascular, la enfermedad coronaria y la enfermedad cardíaca reumática. Los principales factores del estilo de vida que causan enfermedades cardiovasculares y dificultades relacionadas son el consumo de tabaco, una dieta poco saludable y la inactividad física, entre otros. Según la American Heart Association Inc., las muertes relacionadas con enfermedades cardiovasculares registradas en 2020 aumentaron a 928.741 desde 874.613 en 2019. En 2020, la enfermedad coronaria fue la principal causa (41,2%) de muertes atribuibles a enfermedades cardiovasculares en EE. UU. seguido de accidente cerebrovascular (17,3%), hipertensión arterial (12,9%), insuficiencia cardíaca (9,2%), enfermedades de las arterias (2,6%) y otras enfermedades cardiovasculares (16,8%). Además, la Federación Mundial del Corazón predice más de 23 millones de muertes relacionadas con enfermedades cardiovasculares por año para 2030.

Además, los factores de riesgo cardiovascular son altamente prevalentes en Europa Central y Occidental, debido a los hábitos de fumar y las tasas de consumo excesivo de alcohol. , especialmente entre los hombres. Más de 4 millones de europeos mueren cada año a causa de enfermedades cardiovasculares, principalmente debido a enfermedades de las arterias coronarias y accidentes cerebrovasculares. Oriente Medio también tiene una alta tasa de prevalencia de enfermedades cardiovasculares, lo que ha planteado la necesidad de diversas intervenciones, como educación sanitaria, asesoramiento sobre estilos de vida, detección y tratamiento en esta región. Según la Federación Mundial del Corazón, las enfermedades cardiovasculares son la principal causa de muerte en Oriente Medio y el Norte de África y representan más de un tercio de todas las muertes o 1,4 millones de personas al año. Por lo tanto, la creciente prevalencia de enfermedades cardiovasculares impulsa el crecimiento del mercado de globos de angioplastia.

La mayoría considera que las operaciones de angioplastia son seguras, pero se han informado casos de problemas que se desarrollan durante o envejecen la cirugía. Un coágulo de sangre, latidos cardíacos irregulares, daño a un vaso sanguíneo o válvula cardíaca, accidente cerebrovascular, respuesta alérgica al material del stent o al stent liberador de fármaco, reestenosis dentro del stent u obstrucción del interior del stent son algunos de los riesgos involucrados en la angioplastia. operaciones. Si bien algunos de estos riesgos son extremadamente peligrosos, otros pueden incluso ser fatales. Además, en algunas circunstancias, es posible que el paciente no tenga suficiente tiempo para someterse a una angioplastia. Esto suele ocurrir en caso de un ataque cardíaco. Todos estos problemas obstaculizan el crecimiento del mercado de balones de angioplastia.

Perspectivas estratégicas

Segmentación y alcance del informe:

El análisis del mercado de balones de angioplastia se ha llevado a cabo considerando los siguientes segmentos : tipo, aplicación y usuario final.

Análisis segmentario:

Por tipo, el mercado de balones de angioplastia se segmenta en balones normales, balones liberadores de fármacos, balones de corte y balones de puntuación. El segmento de globos normales tuvo la mayor participación de mercado en 2022. Sin embargo, se prevé que el segmento de globos liberadores de fármacos registre la CAGR más alta durante 2022-2030.

Mercado de globos de angioplastia, por tipo: 2022 y 2030

Por aplicación, el mercado de balones de angioplastia se bifurca en periférico y coronario. El segmento coronario tuvo una mayor participación de mercado de balones de angioplastia en 2022 y se prevé que registre la CAGR más alta durante 2022-2030 debido a la creciente prevalencia de enfermedades de las arterias coronarias, especialmente enfermedades cardíacas. Según la actualización de marzo de 2023 de los Centros para el Control y la Prevención de Enfermedades (CDC), la enfermedad coronaria es el tipo de enfermedad cardíaca más prevalente y afecta aproximadamente a 1 de cada 20 personas de 20 años o más. Sin embargo, se prevé que el segmento periférico registre una CAGR más alta durante 2022-2030.

El mercado de balones de angioplastia, según el usuario final, está segmentado en hospitales, centros de cirugía ambulatoria y laboratorios de cateterismo. El segmento de hospitales tuvo la mayor participación de mercado de balones de angioplastia en 2022 y se prevé que registre la CAGR más alta durante 2022-2030.

Análisis regional:

El alcance geográfico del informe de mercado de balones de angioplastia incluye América del Norte, Europa, Asia Pacífico, Medio Oriente y África, y América del Sur y Central. América del Norte tuvo la mayor cuota de mercado en 2022. El crecimiento del mercado en América del Norte está impulsado por la carga cada vez mayor del envejecimiento de la población, el creciente número de lanzamientos de productos y las actividades de I+D para desarrollar balones de angioplastia avanzada.

Panorama competitivo y empresas clave:

Abbott, Boston Scientific Corporation, Cardinal Health, Cook Medical, CR Bard Inc, ENDOCOR GmbH, Medtronic, Spectranetics, BIOTRONIK y Terumo Medical Corporation se encuentran entre las empresas destacadas perfiladas en el mercado de balones de angioplastia. informe. Estas empresas se centran en desarrollar nuevas tecnologías, actualizar productos existentes y ampliar su presencia geográfica para satisfacer la creciente demanda de los consumidores en todo el mundo. Según los comunicados de prensa de la empresa, a continuación se presentan algunos desarrollos clave recientes:

•En marzo de 2023, en los EE. UU., SIS Medical AG presentó el catéter de dilatación PTCA OPN NC con tecnología TWIN-Wall. Al ofrecer un gran rendimiento y seguridad junto con tasas de éxito donde otros globos fallan, el producto amplía las posibilidades de terapia. El catéter OPN NC presenta un diseño de doble pared, que ofrece una resistencia a la presión súper alta con una presión de estallido nominal de 35 atm con un cumplimiento significativamente bajo. En septiembre de 2022, la FDA otorgó a Advanced NanoTherapies una designación de dispositivo innovador ( BDD) por su balón recubierto de fármaco (DCB) SirPlux Duo para tratar la enfermedad de las arterias coronarias. SirPlux Duo DCB ofrece dosis bajas y liberación a largo plazo de ambos compuestos para inhibir el crecimiento celular, lo que da como resultado una potencia máxima que supera a cualquier otro DCB o stent liberador de fármacos. En enero de 2022, el catéter PTCA de puntuación NC Scoreflex recibió la aprobación previa a la comercialización. (PMA) de la Administración de Medicamentos y Alimentos de EE. UU. (FDA). El Scoreflex NC es un catéter PTCA de puntuación indicado para la porción estenótica de novo de una arteria coronaria y la reestenosis dentro del stent en arterias coronarias en pacientes con isquemia coronaria evidente con el fin de mejorar la perfusión miocárdica.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is a angioplasty balloons?

An angioplasty is a technique used to open widen up narrowed or open clogged coronary arteries and restore blood flow. Value-based care, which focuses on cost-effectiveness and patient outcomes, is changing the healthcare sector. The market for angioplasty balloons will be influenced by the capacity of these devices to provide better patient outcomes, lower reduced rates of revascularization, and lower costs as compared to other available treatments. Compared to conventional surgical methods, angioplasty balloons provide a less invasive method of treating clogged arteries. The need for angioplasty balloons is rising as patients and medical professionals show a greater preference for less invasive procedures.

What are the driving factors for the angioplasty balloonss market across the globe?

The factors that are driving the growth of the market are the rising prevalence of cardiovascular diseases and rising increasing preference for minimally invasive procedures.

Who are the major players in the angioplasty balloonss market?

The angioplasty balloonss market majorly consists of players such as Abbott, Boston Scientific Corporation, Cardinal Health, Cook Medical, C. R. Bard Inc, ENDOCOR GmbH, Medtronic, Spectranetics, BIOTRONIK, and Terumo Medical Corporation among others.

Which country is dominating the angioplasty balloonss market?

US holds the largest market share in angioplasty balloonss market due to the increasing cases of heart disease. According to the American Heart Association, due to cardiovascular diseases, one person dies every 34 seconds in the US. In 2020, ~697,000 people in the US died from heart disease, i.e., one in every five deaths.

Which type segment is dominating the angioplasty balloonss market?

The angioplasty balloonss market, based on type, is segmented into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. The normal balloons segment held the largest market share in 2022. However, the drug eluting balloons segment is anticipated to register the highest CAGR during 2022–2030.

Which application segment is dominating the angioplasty balloonss market?

The angioplasty balloonss market, based on application, is is bifurcated into peripheral and coronary. The coronary segment held a larger angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.

Which region is the fastest growing the angioplasty balloonss market?

Asia Pacific is expected to be the fastest-growing region in the angioplasty balloonss market. The region occupies a significant position in the global angioplasty balloons market and is expected to demonstrate a promising growth trajectory during the forecast period. The driving factors for the growth of the market are the increasing prevalence of cardiovascular diseases, growing aging population, improving healthcare infrastructure, and rising awareness about minimally invasive procedures.

Which end user segment is dominating the angioplasty balloonss market?

The angioplasty balloonss market, based on end user, is segmented into hospitals, ambulatory surgery centers, and cath labs. The hospitals segment held the largest angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.

The List of Companies - Angioplasty Balloons Market

  1. Abbott
  2. Boston Scientific Corporation
  3. Cardinal Health
  4. Cook Medical
  5. C. R. Bard Inc
  6. ENDOCOR GmbH
  7. Medtronic
  8. Spectranetics
  9. BIOTRONIK
  10. Terumo Medical Corporation     

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports